ClinicalTrials.gg

Prevail Therapeutics clinical trials

Acquired by Eli Lilly and Company, Jan 22, 2021 · source ↗

The registry lists 5 studies whose lead sponsor is Prevail Therapeutics. 1 is recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 22, 2026.

Before and after it joined Eli Lilly and Company

First submitted before Prevail Therapeutics became part of Eli Lilly and Company
3
First submitted after Prevail Therapeutics became part of Eli Lilly and Company
2
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs Prevail Therapeutics’ studies test, most studies first; none is open now — 3 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

Coming up

1 of Prevail Therapeutics’ studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. 1F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

All 5 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now120%
  • Under way, not recruiting480%

Phase

  • Phase 15
  • Phase 24

Where

  • United States5
  • United Kingdom3
  • Australia2
  • Spain2
  • Germany2
  • Netherlands1

Over the years

  1. 220
  2. 21
  3. 22
  4. 23
  5. 24
  6. 25
  7. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Prevail Therapeutics5 studies

Something wrong with this grouping? Tell us on the Eli Lilly and Company page.

Studies

Recruiting first, then most recently updated. Showing 5 of 5. All Eli Lilly and Company studies →